Nitrosamines can be formed through various chemical processes, including the reaction between nitrites and secondary amines in certain conditions. It is a N-Nitroso of secondary amine present in Sacubitril. Nitrosamines are part of a broader class of compounds known as N-nitroso compounds.
Chemically, sacubitril is the prodrug form of sacubitrilat, the active neprilysin inhibitor. The chemical name for sacubitrilat is (2S,4S)-2-ethoxy-4-{[(3S)-3-methyl-4-(methylamino)-4-oxopentanoyl]amino}-5-propan-2-yl-5H-imidazo[4,5-d]pyridazin-1-one. Sacubitril/valsartan is a combination medication used in the treatment of heart failure with reduced ejection fraction (HFrEF). Sacubitril inhibits neprilysin, an enzyme that breaks down natriuretic peptides involved in cardiovascular homeostasis. This inhibition leads to increased levels of natriuretic peptides, promoting vasodilation and natriuresis. Valsartan, an angiotensin receptor blocker, complements this action by blocking the vasoconstrictor effects of the renin-angiotensin-aldosterone system. The combined effect of sacubitril/valsartan helps improve cardiac function, reduce symptoms, and enhance outcomes in patients with HFrEF.
Buy high quality N-Nitroso Sacubitril Valsartan from Chemicea Pharmaceuticals. Chemicea Pharmaceuticals is one of the leading manufacturer and exporter of N-Nitroso Sacubitril Valsartan

N-Nitroso Sacubitril Valsartan

CAT. No. CP-S18019
CAS. No. NA
Mol. F. C24H29NO5 : C24H28N6O4
Mol. Wt. 411.5 : 464.53
Stock Status Please Enquire
VIEW COA Sample PDF

Product Description


  • Category:Impurity Standards
  • Synonyms:NA
  • Chemical Name:N-((2\'-(1-Nitroso-1H-tetrazol-5-yl)-[1,1\'-biphenyl]-4-yl)methyl)-N-pentanoyl-L-valine compound with 4-(((2S,4R)-1-([1,1\'-biphenyl]-4-yl)-5-ethoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoic acid (1:1)

Request for Quotation : N-Nitroso Sacubitril Valsartan

Please enter pack size
Please enter quantity
Please enter phone number
Enter 10 digit contact number
Enter only number
Please enter your full name
Please enter only alphabets
Please enter company name
Please enter your valid email
Please enter your valid email id
Please select country
Please select state
Please select city

Please select captcha
Please wait...